shutterstock_298303490_vonaua
VonaUA / Shutterstock.com
19 February 2019Big Pharma

SPC waiver stockpiling provision attracts criticism

While the final text of the European Council’s agreement on a supplementary protection certificate (SPC) manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
18 April 2019   The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

More on this story

Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
18 April 2019   The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

More on this story

Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
18 April 2019   The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.